Received: 1 September 2020
Accepted: 18 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: The study protocol was approved by the University of Foggia Ethics Committee (Nov. 8, 2017. Registration Number 871-16) was carried out in agreement with the provisions of the Declaration of Helsinki. Written informed consent was obtained from all patients.
: Not applicable.
: These Authors (VF, SI, PGN, MP), listed in alphabetical order, are shareholders at Janus Pharma Srl.